Suchergebnisse - "Wesson, William"

PubPharm (9)

1

Safety and efficacy of eltrombopag in patients with post-CAR T cytopenias

enthalten in: European journal of haematology | 2024

von Wesson, W. | Ahmed, N. | Rashid, A. | +10

2

Safety and efficacy of eltrombopag in patients with post‐ CAR T cytopenias

enthalten in: European Journal of Haematology | 2024

von Wesson, W. | Ahmed, N. | Rashid, A. | +10

3

Impact of Cytogenetic Abnormalities, Induction and Maintenance Regimens on Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma : A Decade-Long Real-World Experience

enthalten in: Journal of hematology | 2023

von Thurlapati, A. | Wesson, W. | Davis, J. | +10

4

Efficacy and Safety of CD34+ Stem Cell Boost for Delayed Hematopoietic Recovery After BCMA Directed CAR T-cell Therapy

enthalten in: Transplantation and cellular therapy | 2023

von Davis, J. | Sborov, D. | Wesson, W. | +5

5

Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin Lymphoma

enthalten in: Transplantation and cellular therapy | 2023

von Ahmed, N. | Wesson, W. | Mushtaq, M. | +16

6

Dawn of Hope for Improved Access to BCMA Therapy : Chimeric Antigen Receptor T Cell and Bispecific Products

enthalten in: Transplantation and cellular therapy | 2023

von Ahmed, N. | Wesson, W. | Abdallah, A.

CommentOn: Transplant Cell Ther. 2023 Apr;29(4):255-258. - PMID 36681151

7

"Waitlist mortality" is high for myeloma patients with limited access to BCMA therapy

enthalten in: Frontiers in oncology | 2023

von Ahmed, N. | Wesson, W. | Mushtaq, M. | +11

8

Characteristics of measurable residual disease assessment in myeloma : a review of clinical trials from 2015-2020

enthalten in: Blood cancer journal | 2022

von Van Oekelen, O. | Birrer, N. | Wesson, W. | +7

9

Characteristics of clinical trials for haematological malignancies from 2015 to 2020 : A systematic review

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Wesson, W. | Galate, V. | Sborov, D. | +6

CommentIn: Eur J Cancer. 2022 May;167:161-163. - PMID 35246369

1
[1]